De Maeyer M - Search Results

1

Staphylokinase-specific cell-mediated immunity in humans.

Warmerdam PA, Vanderlick K, Vandervoort P, De Smedt H, Plaisance S, De Maeyer M, Collen D. Warmerdam PA, et al. Among authors: de smedt h, de maeyer m. J Immunol. 2002 Jan 1;168(1):155-61. doi: 10.4049/jimmunol.168.1.155. J Immunol. 2002. PMID: 11751958

2

Elimination of a human T-cell region in staphylokinase by T-cell screening and computer modeling.

Warmerdam PA, Plaisance S, Vanderlick K, Vandervoort P, Brepoels K, Collen D, De Maeyer M. Warmerdam PA, et al. Among authors: de maeyer m. Thromb Haemost. 2002 Apr;87(4):666-73. Thromb Haemost. 2002. PMID: 12008950

3

Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.

Collen D, Sinnaeve P, Demarsin E, Moreau H, De Maeyer M, Jespers L, Laroche Y, Van de Werf F. Collen D, et al. Among authors: de maeyer m. Circulation. 2000 Oct 10;102(15):1766-72. doi: 10.1161/01.cir.102.15.1766. Circulation. 2000. PMID: 11023930 Clinical Trial.

4

Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex.

Jespers L, Van Herzeele N, Lijnen HR, Van Hoef B, De Maeyer M, Collen D, Lasters I. Jespers L, et al. Among authors: de maeyer m. Biochemistry. 1998 May 5;37(18):6380-6. doi: 10.1021/bi972807i. Biochemistry. 1998. PMID: 9572854

5

Structural and functional basis of plasminogen activation by staphylokinase.

Jespers L, Vanwetswinkel S, Lijnen HR, Van Herzeele N, Van Hoef B, Demarsin E, Collen D, De Maeyer M. Jespers L, et al. Among authors: de maeyer m. Thromb Haemost. 1999 Apr;81(4):479-85. Thromb Haemost. 1999. PMID: 10235424

6

Guiding a docking mode by phage display: selection of correlated mutations at the staphylokinase-plasmin interface.

Jespers L, Lijnen HR, Vanwetswinkel S, Van Hoef B, Brepoels K, Collen D, De Maeyer M. Jespers L, et al. Among authors: de maeyer m. J Mol Biol. 1999 Jul 9;290(2):471-9. doi: 10.1006/jmbi.1999.2887. J Mol Biol. 1999. PMID: 10390345

7

Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).

Arza B, De Maeyer M, Félez J, Collen D, Lijnen HR. Arza B, et al. Among authors: de maeyer m. Eur J Biochem. 2001 Feb;268(3):826-31. doi: 10.1046/j.1432-1327.2001.01943.x. Eur J Biochem. 2001. PMID: 11168424 Free article.

8

Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.

Monaco G, Decrock E, Akl H, Ponsaerts R, Vervliet T, Luyten T, De Maeyer M, Missiaen L, Distelhorst CW, De Smedt H, Parys JB, Leybaert L, Bultynck G. Monaco G, et al. Among authors: de smedt h, de maeyer m. Cell Death Differ. 2012 Feb;19(2):295-309. doi: 10.1038/cdd.2011.97. Epub 2011 Aug 5. Cell Death Differ. 2012. PMID: 21818117 Free PMC article.

9

Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimer.

Laroche Y, Demaeyer M, Stassen JM, Gansemans Y, Demarsin E, Matthyssens G, Collen D, Holvoet P. Laroche Y, et al. J Biol Chem. 1991 Sep 5;266(25):16343-9. J Biol Chem. 1991. PMID: 1885569 Free article.

10

In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody.

Gilles JG, Grailly SC, De Maeyer M, Jacquemin MG, VanderElst LP, Saint-Remy JM. Gilles JG, et al. Among authors: de maeyer m. Blood. 2004 Apr 1;103(7):2617-23. doi: 10.1182/blood-2003-07-2207. Epub 2003 Dec 11. Blood. 2004. PMID: 14670927 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page